| Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus L Priyamvada, KM Quicke, WH Hudson, N Onlamoon, J Sewatanon, ... Proceedings of the National Academy of Sciences 113 (28), 7852-7857, 2016 | 658 | 2016 |
| Monkeypox outbreak—Nine states, May 2022: Weekly/June 10, 2022/71 (23); 764–769 FS Minhaj, YP Ogale, F Whitehill, J Schultz, M Foote, W Davidson, ... American Journal of Transplantation 22 (8), 2104-2110, 2022 | 379 | 2022 |
| Monkeypox in a traveler returning from Nigeria—Dallas, Texas, July 2021 AK Rao MMWR. Morbidity and Mortality Weekly Report 71, 2022 | 265 | 2022 |
| SARS-CoV-2–associated deaths among persons aged 21 years—United States, February 12–July 31, 2020 D Bixler MMWR. Morbidity and mortality weekly report 69, 2020 | 227 | 2020 |
| Influenza virus reassortment occurs with high frequency in the absence of segment mismatch N Marshall, L Priyamvada, Z Ende, J Steel, AC Lowen PLoS pathogens 9 (6), e1003421, 2013 | 214 | 2013 |
| Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology. L Priyamvada, W Hudson, R Ahmed, J Wrammert Emerging microbes & infections 6 (1), 1-6, 2017 | 139 | 2017 |
| B cell responses during secondary dengue virus infection are dominated by highly cross-reactive, memory-derived plasmablasts L Priyamvada, A Cho, N Onlamoon, NY Zheng, M Huang, Y Kovalenkov, ... Journal of virology 90 (12), 5574-5585, 2016 | 136 | 2016 |
| Cross-reactive dengue virus antibodies augment Zika virus infection of human placental macrophages MG Zimmerman, KM Quicke, JT O'Neal, N Arora, D Machiah, ... Cell host & microbe 24 (5), 731-742. e6, 2018 | 133 | 2018 |
| Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab A Cho, B Bradley, R Kauffman, L Priyamvada, Y Kovalenkov, R Feldman, ... JCI insight 2 (12), 2017 | 65 | 2017 |
| Humoral immune responses against zika virus infection and the importance of preexisting flavivirus immunity L Priyamvada, MS Suthar, R Ahmed, J Wrammert The Journal of infectious diseases 216 (suppl_10), S906-S911, 2017 | 52 | 2017 |
| Gammaherpesvirus co-infection with malaria suppresses anti-parasitic humoral immunity CG Matar, NR Anthony, BM O’Flaherty, NT Jacobs, L Priyamvada, ... PLoS pathogens 11 (5), e1004858, 2015 | 43 | 2015 |
| Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo L Priyamvada, WC Carson, E Ortega, T Navarra, S Tran, TG Smith, ... Vaccine 40 (50), 7321-7327, 2022 | 40 | 2022 |
| Conserved Oligomeric Golgi (COG) complex proteins facilitate orthopoxvirus entry, fusion and spread S Realegeno, L Priyamvada, A Kumar, JB Blackburn, C Hartloge, ... Viruses 12 (7), 707, 2020 | 32 | 2020 |
| New methylene blue derivatives suggest novel anti-orthopoxviral strategies L Priyamvada, J Burgado, M Baker-Wagner, A Kitaygorodskyy, V Olson, ... Antiviral Research 191, 105086, 2021 | 25 | 2021 |
| Pediatric Mortality Investigation Team D Bixler, AD Miller, CP Mattison, B Taylor, K Komatsu, X Peterson Pompa, ... SARS-CoV-2-associated deaths among persons aged 21, 0 | 24 | |
| Pre-existing dengue immunity drives a DENV-biased plasmablast response in ZIKV-infected patient SK Bhaumik, L Priyamvada, RC Kauffman, L Lai, MS Natrajan, A Cho, ... Viruses 11 (1), 19, 2018 | 21 | 2018 |
| Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry L Priyamvada, WW Kallemeijn, M Faronato, K Wilkins, CS Goldsmith, ... PLoS Pathogens 18 (10), e1010662, 2022 | 18 | 2022 |
| Severe disease during both primary and secondary dengue virus infections in pediatric populations C Aggarwal, H Ahmed, P Sharma, ES Reddy, K Nayak, M Singla, ... Nature medicine 30 (3), 670-674, 2024 | 16 | 2024 |
| Evidence of mpox virus infection among persons without characteristic lesions or rash presenting for first dose of JYNNEOS vaccine—District of Columbia, August 2022 YP Ogale, N Baird, MB Townsend, I Berry, I Griffin, M Lee, P Ashley, ... Clinical Infectious Diseases 77 (2), 298-302, 2023 | 12 | 2023 |
| Discovery of Retro-1 analogs exhibiting enhanced anti-vaccinia virus activity L Priyamvada, P Alabi, A Leon, A Kumar, S Sambhara, VA Olson, JK Sello, ... Frontiers in Microbiology 11, 603, 2020 | 12 | 2020 |
Rafi AhmedDirector of Emory Vaccine CenterVerified email at emory.edu